The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

The company said the agency's hold was "not related to the drug,” dubbed AMG 513, and that discussions were underway to ...

The economic burden of obesity is also significant. In the Finger Lakes, excess medical spending due to obesity is estimated ...

Weight-loss drugs such as Ozempic have been a breakthrough because they eliminate the need to cut back or compensate by ...

A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a ...

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

Offering expertise on the program are OB-GYN Dr. Donna G. Ivery, Neumours infection expert Chad Neilsen, and Dr. Dacre Knight ...

Major heart health risk factors like obesity, diabetes and high blood pressure remain on the rise in the United States, ...

Comprehensive study exposes critical health risks of obesity, including diabetes, heart disease, and cancer, while offering ...